health · HHS-NIH11
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-27-112
Total Program Funding
$6.3M
Expected Awards
1
Deadline
November 9, 2026
GRANTQUICK SUMMARYPlain-English Overview
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed). National Institutes of Health. The primary purpose of this FOA is to support the EDIC Research Center in continuing long-term follow-up of the EDIC cohort to study the development and progression of complications in type 1 diabetes (T1D). The research will address severe microvascular disease, cardiovascular and liver... $6,300,000 total program funding; ~1 awards expected.
Who Should Apply
Public universities/colleges, Private universities/colleges
Who Should NOT Apply
Individuals and organizations outside the specified eligible types
Key Requirements (Plain English)
- •This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: Very high — extremely limited awards available
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $6.3M
- Expected Number of Awards
- 1
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK_DEM@nih.gov
NIDDK_DEM@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov